Astrazeneca Canada Inc.
AstraZeneca Canada Inc., a subsidiary of the global biopharmaceutical company AstraZeneca PLC, is headquartered in Canada and operates extensively across the country. Founded in 1999, AstraZeneca has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular, renal, and respiratory diseases. With a commitment to research and development, AstraZeneca Canada is renowned for its unique portfolio of products, including groundbreaking therapies that address unmet medical needs. The company has achieved significant milestones, including advancements in cancer treatment and the development of vaccines. AstraZeneca's strong market position is underscored by its dedication to improving patient outcomes and its contributions to public health, making it a key player in the Canadian healthcare landscape.
DitchCarbon Score
How does Astrazeneca Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astrazeneca Canada Inc.'s score of 53 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Astrazeneca Canada Inc.'s reported carbon emissions
AstraZeneca Canada Inc. currently does not have publicly available carbon emissions data for the most recent year, nor are there specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. However, as a major player in the pharmaceutical industry, AstraZeneca is expected to align with industry standards and best practices regarding sustainability and emissions reduction. The company may be involved in broader corporate initiatives aimed at addressing climate change, but specific details are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Astrazeneca Canada Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
